An hour may change everything for patients with lumbar spinal stenosis (LSS). Find out how this minimally invasive, outpatient procedure, which has a safety profile similar to an epidural steroid injection (ESI), may help you stand longer and walk farther with less pain.
Learn More
Pain or numbness in lower back when standing
Pain, numbness or tingling in legs or buttocks when walking
Relief when sitting or leaning forward
Help your LSS patients, even those with comorbidities, by removing a major root cause of their neurogenic claudication. Move to mild® to provide patients with long-term relief using a therapy that has a safety profile equivalent to an ESI, but with lasting results. Learn more about the minimally invasive mild® Procedure’s key benefits, clinical outcomes and how it can be incorporated into your treatment algorithm.
Learn MoreAre epidural steroid injections (ESIs) falling short for your patients? Make the #MOVE2mild! Published data supports the use of the Mild Procedure after the first ESI fails.* Give your patients a safe, durable option for their lumbar spinal stenosis (#LSS) pain by incorporating Mild early in your treatment algorithm.*
*View clinical data at the #linkinbio
Look for the ligament, it’s a common problem, even in patients with comorbidities. Remove the problem with Mild and leave nothing behind.
Mild made a major impact during @pacificspineandpainsociety and @painweek in Las Vegas and we couldn’t have done it without the leadership of many outstanding doctors. We would like to extend our gratitude to Drs. @drpryz and @jassalmd for leading the Mild Procedure Symposium geared toward Primary Care Physicians (PCPs) and to Drs. @paincsd, @dr.khemlani, and @stangolovac for their leadership in the PSPS Cadaveric Lab stations.
Thank you as well to Dr. @dsayed123 for your @painweek MIST lecture, Dr. @evolve_restorative_center for your PSPS Mild lecture, and to Dr. @nvadvancedpain for your @painweek PCP Panel. Congratulations, as well, to Dr. @steven_falowski on your winning abstract.
Is this patient a Mild Procedure candidate?
Case history: 71 year-old male with a history of epidural steroid injections (ESIs) and lumbar neurotomy with limited relief; presenting with back and leg pain at an 8 to 10 (out of 10) that worsens with standing and walking; inability to walk more than 5-10 minutes, and relief with sitting and flexion. Imaging indicated hypertrophic ligamentum flavum ≥ 2.5 mm.
Answer: Yes! The featured patient was an excellent Mild candidate who saw significant improvement within one month post-procedure. After the Mild Procedure, the patient was able to walk and stand for 25 minutes with no pain.
Read the full case study at the #linkinbio!
September is #PainAwarenessMonth. Your patients don’t have to live in pain due to lumbar spinal stenosis (#LSS). Make the #MOVE2mild in your practice and help them get back to doing what they enjoy.
Learn more about the Mild Procedure for LSS at the #linkinbio.
At the @aspn_painneuro 2021 meeting in Miami, several abstracts highlighted recent data that supports use of the Mild Procedure as a first line therapy. Additionally, a panel of prominent Interventional Pain Physicians convened to discuss their experiences and clinical pearls for implementing the Mild Procedure in their practices. The consensus? The abstract authors and panelists repeatedly confirmed the rationale, supporting evidence and benefits of making the #MOVE2mild as a first line therapy for #LumbarSpinalStenosis (LSS).
➡️ Swipe to see why leading practices are moving to Mild and read the full blog at the #linkinbio
Thank you abstract authors and panelists: Drs. Mark Coleman, @organicstrings, @timdeer30a, @steven_falowski, @drjessicajameson, @jassalmd, Michael Leong, Nagy Mekhail, Jason Pope, @drpryz, @painkiller_photos, @dsayed123, and Lindsay Shroyer, and APP Christine Christensen.
Team Vertos has fantastic career opportunities for a variety of positions. Join a motivated team striving to help #LumbarSpinalStenosis (LSS) patients find the relief they need in a minimally invasive way.
We currently have openings for: District Sales Manager, District Sales Specialist, Principal R&D Engineer, Reimbursement Specialist, and Tableau/Salesforce Developer.
Learn more about joining Team Vertos at the #linkinbio!
A change in your #lumbarspinalstenosis (LSS) treatment algorithm can make a world of difference. 🌎 By accelerating his practice's assessment of epidural efficacy, Dr. Jason Pope has been able to #MOVE2mild earlier in the treatment plan and help reduce his patients' "epidural exhaustion" with a durable* option for LSS.
*View clinical data and learn more at the link in bio.
Congratulations to the @wipm_society on a successful inaugural annual meeting. In both hands-on and didactic sessions, distinguished clinicians shared clinical pearls, the latest data, and treatment strategies that support expanding the Mild Procedure to more patients earlier in their treatment algorithm. By educating their peers on why they #MOVE2mild and the benefits the Mild Procedure offers #LumbarSpinalStenosis patients, these inspiring women are helping put more patients on the path to relief.
Special thanks to @drweisbein and @drjessicajameson for hosting the Mild demonstration lab. We appreciate your continued support.
The @aspn_painneuro CME webinar, "Reviewing MRIs: A Collaborative Approach to Patient Selection" was a success and it's not over yet! The webinar and CME is available to watch and claim for one year, so if you missed it, you can still hear the expert physician and APP panel discuss how to match more patients with the right treatments sooner by working together. Access the webinar now at the link in bio.
A big thank you to panel members leading this CME event, including Tim Deer, MD, Navdeep Jassal, MD, Eugene Paik, MD, Dawood Sayed, MD, Christine Christensen, NP, Ashley Comer, NP and Zohra Hussaini, APRN!
#MOVE2mild after the first epidural steroid injection (ESI) fails. ESIs typically bring temporary relief, but do not address the major root cause of lumbar spinal stenosis (LSS). The Mild Procedure removes the problem and leaves nothing behind. The Mild Procedure has a safety profile equivalent to an ESI with proven 5 year durability*. Help your patients avoid epidural exhaustion— #MOVE2mild and put them on the path to lasting relief.
*View the clinical data at the link in bio.
A broad spectrum of lumbar spinal stenosis (LSS) patients have experienced increased mobility, reduced pain and restored quality of life with the minimally invasive #MildProcedure. From patient identification to significant outcomes, read case studies on how leading HCPs nationwide expanded their patient selection and made the #MOVE2mild at the link in bio. Thank you to Mild providers Dr. Aaron Calodney, Dr. Mark Coleman, @dr.khemlani, @timdeer30a, Ashley Comer, APRN, NP-C, @anjum.bux, Kyla Anderson, APRN, @jassalmd, @drpryz and @paindoc13 for sharing your patient stories and advancing patient care.
Mild is always on the move. In Miami, the MOTION Study team joined together for an in-person working session in advance of the 1-year publication of their landmark, Level 1 evidence supporting functional improvement, procedure durability, and safety.
Principal Investigator, @timdeer30a gathered with study investigators and coordinators @dsayed123, @stangolovac, Dr. Aaron Calodney, Dr. Brent Chafin, Dr. Shrif Costandi, @jassalmd, Dr. Wayne Nguyen, @paindoc13, and Nicole Ladesich to discuss how the real-world evidence generated in the randomized controlled study supports the use of Mild as early first-line therapy. #MildProcedure
What was the biggest news at the @aspn_painneuro 2021 Conference? New #MildProcedure data! Five poster presentations highlight the reasons more practices are moving to Mild as a first-line therapy for lumbar spinal stenosis (LSS).
Must-see Mild outcomes include: @timdeer30a with Level 1 evidence on the superiority of Mild and conventional medical management (CMM) versus CMM-alone; @drpryz on performing Mild immediately upon diagnosis of central LSS with neurogenic claudication, or after the first ESI fails.
Looking to explore procedural techniques? The Mild Streamlined Technique gains backing from: @dsayed123 and his co-authors’ multi-center findings on efficacy and @jassalmd with APP Christine Christensen’s safety data. Dr. Jason Pope also demonstrates safety with the intraprocedural use of osteal landmarks instead of an epidurogram. See the data now at link in bio!
At #ASPN2021, we had the opportunity to convene with an engaged group of Mild advocates from across the country, who provided their perspectives on the advantages of this minimally invasive lumbar decompression procedure for lumbar spinal stenosis (LSS) patients.
We’re beyond inspired to see so many leading physicians in the interventional pain community coming together to help make Mild the standard of care for LSS patients. Between sharing patient stories, discussing best practices, and reviewing new data, the passion for helping more LSS patients have access to Mild, earlier in the treatment journey was powerful.
Thank you to Dr. Aaron Calodney, @pain4eemd, @anjumbux, Dr. Brent Chafin, @organicstrings, @dsayed123, @nvadvancedpain, @harrysukumaran, @drweisbein, @painkiller_photos, @jmshahmd, Dr. Lindsay Shroyer, Dr. Mark Coleman, @jassalmd, @_dr.azeem, @drpryz, @sxl08md, @stangolovac, @timdeer30a, Dr. Michael Verdolin, @drajayantonymd, Dr. Erika Peterson, ...
How are Mild Masters spending their time in Miami before @aspn_painneuro kicks off? In the Mild Playground Lab, sharing best practices and exploring techniques as we continue to advance procedure efficiency and make Mild accessible for more lumbar spinal stenosis (LSS) patients with neurogenic claudication.
The Mild Playground Lab was a hands-on experience where treating physicians got 1:1 engagement with our research and development, product engineering, and clinical specialist teams to identify and investigate exciting new opportunities for the #MildProcedure.
Benyamin RM, Staats PS, MiDAS ENCORE Investigators. mild® is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE Randomized Controlled Trial. Pain Physician. 2016;19(4):229-242.
Mekhail N, Costandi S, Abraham B, Samuel SW. Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression. Pain Pract. 2012;12(6):417-425. doi:10.1111/j.1533-2500.2012.00565.x.
2012 data from Health Market Sciences report for Vertos Medical 2013.
Data on file with Vertos Medical.
Staats PS, Chafin TB, Golvac S, et al. Long-term safety and efficacy of minimally invasive lumbar decompression procedure for the treatment of lumbar spinal stenosis with neurogenic claudication: 2-year results of MiDAS ENCORE. Reg Anesth Pain Med. 2018;43:789-794. doi:10.1097/AAP.0000000000000868.
Based on mild® Procedure data collected in all clinical studies. Major complications are defined as dural tear and blood loss requiring transfusion.
MiDAS ENCORE responder data. On file with Vertos Medical.
Jain S, Deer TR, Sayed D, et al. Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety. Pain Manag. 2020;10(5). https://doi.org/10.2217/pmt-2020-0037. Accessed June 1, 2020.
Deer TR, Grider JS, Pope JE, et al. The MIST Guidelines: the Lumbar Spinal Stenosis Consensus Group guidelines for minimally invasive spine treatment. Pain Pract. 2019;19(3)250-274. doi:10.1111/papr.12744.
Hansson T, Suzuki N, Hebelka H, Gaulitz A. The narrowing of the lumbar spinal canal during loaded MRI: the effects of the disc and ligamentum flavum. Eur Spine J. 2009;18(5):679-686. doi:10.1007/s00586-009-0919-7.
Treatment options shown are commonly offered once conservative therapies (e.g., physical therapy, pain medications, chiropractic) are not providing adequate relief. This is not intended to be a complete list of all treatments available. Doctors typically recommend treatments based on their safety profile, typically prioritizing low risk/less aggressive procedures before higher risk/more aggressive procedures, but will determine which treatments are appropriate for their patients.
Although the complication rate for the mild® Procedure is low, as with most surgical procedures, serious adverse events, some of which can be fatal, can occur, including heart attack, cardiac arrest (heart stops beating), stroke, and embolism (blood or fat that migrates to the lungs or heart). Other risks include infection and bleeding, spinal cord and nerve injury that can, in rare instances, cause paralysis. This procedure is not for everyone. Physicians should discuss potential risks with patients. For complete information regarding indications for use, warnings, precautions, and methods of use, please reference the devices’ Instructions for Use.
Patient stories on this website reflect the results experienced by individuals who have undergone the mild® Procedure. Patients are not compensated for their testimonial. The mild® Procedure is intended to treat lumbar spinal stenosis (LSS) caused by ligamentum flavum hypertrophy. Although patients may experience relief from the procedure, individual results may vary. Individuals may have symptoms persist or evolve or other conditions that require ongoing medication or additional treatments. Please consult with your doctor to determine if this procedure is right for you.
Reimbursement, especially coding, is dynamic and changes every year. Laws and regulations involving reimbursement are also complex and change frequently. Providers are responsible for determining medical necessity and reporting the codes that accurately describe the work that is done and the products and procedures that are furnished to patients. For this reason, Vertos Medical strongly recommends that you consult with your payers, your specialty society, or the AMA CPT regarding coding, coverage and payment.
Vertos Medical cannot guarantee coding, coverage, or payment for products or procedures. View our Billing Guide.
Vertos is an equal employment opportunity workplace committed to pursuing and hiring a diverse workforce. We strive to grow our team with highly skilled people who share our culture and values. All qualified applicants will receive consideration for employment without regard to sex, age, color, race, religion, marital status, national origin, ancestry, sexual orientation, gender identity, physical & mental disability, medical condition, genetic information, veteran status, or any other basis protected by federal, state or local law.
Hall S, Bartleson JD, Onofrio BM, Baker HL Jr, Okazaki H, O’Duffy JD. Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med. 1985;103(2):271-275. doi:10.7326/0003-4819-103-2-271.
Kalichman L, Cole R, Kim DH, et al. Spinal stenosis prevalence & association with symptoms: The Framingham Study. Spine J. 2009;9(7):545-550. doi:10.1016/j.spinee.2009.03.005.
Fukusaki M, Kobayashi I, Hara T, Sumikawa K. Symptoms of spinal stenosis do not improve after epidural steroid injection. Clin J Pain. 1998;14(2):148-151. doi:10.1097/00002508-199806000-00010.
Mekhail N, Costandi S, Nageeb G, Ekladios C, Saied O. The durability of minimally invasive lumbar decompression procedure in patients with symptomatic lumbar spinal stenosis: Long-term follow-up [published online ahead of print, 2021 May 4]. Pain Pract. 2021;10.1111/papr.13020. doi:10.1111/papr.13020
Friedly JL, Comstock BA, Turner JA, et al. Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized Trial. Arch Phys Med Rehabil. 2017;98(8):1499-1507.e2. doi:10.1016/j.apmr.2017.02.029
Pope J, Deer TR, Falowski SM. A retrospective, single-center, quantitative analysis of adverse events in patients undergoing spinal stenosis with neurogenic claudication using a novel percutaneous direct lumbar decompression strategy. J Pain Res. 2021;14:1909-1913. doi: 10.2147/JPR.S304997
Pryzbylkowski P, Bux A, Chandwani K, et al. Minimally invasive direct decompression for lumbar spinal stenosis: impact of multiple prior epidural steroid injections [published online ahead of print, 2021 Aug 4]. Pain Manag. 2021;10.2217/pmt-2021-0056. doi:10.2217/pmt-2021-0056
Abstract presented at: American Society of Pain and Neuroscience Annual Conference; July 22-25, 2021; Miami Beach, FL.
